Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up (Q43149681)
Jump to navigation
Jump to search
scientific article published in May 2010
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up |
scientific article published in May 2010 |
Statements
1 reference
Efficacy and safety of sulfonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up (English)
1 reference
Wojciech Mlynarski
1 reference
Tomasz Klupa
1 reference
Jan Skupien
1 reference
Maciej T Malecki
1 reference
Anna Noczynska
1 reference
Elzbieta Kozek
1 reference
Joanna Nazim
1 reference
Barbara Mirkiewicz-Sieradzka
1 reference
Agnieszka Zubkiewicz-Kucharska
1 reference
1 May 2010
1 reference
1 reference
Identifiers
1 reference